China Resources Double-crane Pharmaceutical Co., Ltd. Class ASSE: 600062

Announcement on the Receipt of the Drug Supplement Approval Notice for Potassium Chloride Injection by Wholly-Owned Subsidiary Anhui Double-Crane Pharmaceutical Co., Ltd.

· Issued by China Resources Double-crane Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on the Receipt of the Drug Supplement Approval Notice for Potassium Chloride Injection by Wholly-Owned Subsidiary Anhui Double-Crane Pharmaceutical Co., Ltd.

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment